← Back to Clinical Trials
Recruiting NCT06814054

NCT06814054 Carotid Artery Corrected Flow Time and Inferior Vena Cava Collapsibility Index for Prediction of Hypotension After Induction of General Anesthesia in Geriatric Patients Undergoing Elective Surgery

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06814054
Status Recruiting
Phase
Sponsor Tanta University
Condition Geriatrics
Study Type OBSERVATIONAL
Enrollment 189 participants
Start Date 2025-03-01
Primary Completion 2026-04

Eligibility & Interventions

Sex All sexes
Min Age 65 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Carotid Artery Corrected Flow Time measurementInferior vena cava collapsibility index

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 189 participants in total. It began in 2025-03-01 with a primary completion date of 2026-04.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

In this observational study, we will assess cFT by Carotid ultrasound and IVC collapsibility index for prediction of hypotension after induction of general anesthesia in geriatric patients undergoing elective surgery.

Eligibility Criteria

Inclusion Criteria: * American Society of Anaesthesiologists Physical Status I to Ⅱ * receiving general anesthesia for elective surgery * fasted for at least 6 to 8 hours were recruited in this study Exclusion Criteria: * • patients who refused to participate in the study * American Society of Anaesthesiologists Physical Status Ⅲ or Ⅳ * Patients with a history of peripheral arterial diseases or atherosclerosis * Patients with body mass index of greater than 30 kg/m2 * Patients with arrhythmia or cardiomyopathy * Chronic obstructive pulmonary disease (COPD) * baseline systolic arterial pressure (SAP) ≥ 180 mmHg or \< 90mmHg * Any episode of desaturation or difficult intubation during general anasethia induction

Contact & Investigator

Central Contact

tarek AH Mostafa

✉ dr.tarek311@yahoo.com

📞 01003591332

Principal Investigator

tarek Mostafa

PRINCIPAL INVESTIGATOR

tanta university, faculty of medicine

Frequently Asked Questions

Who can join the NCT06814054 clinical trial?

This trial is open to participants of all sexes, aged 65 Years or older, studying Geriatrics. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06814054 currently recruiting?

Yes, NCT06814054 is actively recruiting participants. Contact the research team at dr.tarek311@yahoo.com for enrollment information.

Where is the NCT06814054 trial being conducted?

This trial is being conducted at Tanta, Egypt.

Who is sponsoring the NCT06814054 clinical trial?

NCT06814054 is sponsored by Tanta University. The principal investigator is tarek Mostafa at tanta university, faculty of medicine. The trial plans to enroll 189 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology